Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it?
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-12-23
DOI
10.1093/eurheartj/ehx811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells
- (2017) Arun Sharma et al. Science Translational Medicine
- Cardiovascular Toxicities Associated with Cancer Immunotherapies
- (2017) Daniel Y. Wang et al. Current Cardiology Reports
- Development of vascularized iPSC derived 3D-cardiomyocyte tissues by filtration Layer-by-Layer technique and their application for pharmaceutical assays
- (2016) Yuto Amano et al. Acta Biomaterialia
- Human engineered heart tissue as a model system for drug testing
- (2016) Alexandra Eder et al. ADVANCED DRUG DELIVERY REVIEWS
- Update on cardiotoxicity of anti-cancer treatments
- (2016) Gian Marco Rosa et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Translation of Human-Induced Pluripotent Stem Cells
- (2016) Nazish Sayed et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Toxic Effects of Targeted Cancer Therapies
- (2016) Javid J. Moslehi NEW ENGLAND JOURNAL OF MEDICINE
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Insights Into Molecular, Cellular, and Functional Phenotypes
- (2015) I. Karakikes et al. CIRCULATION RESEARCH
- Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology
- (2015) H. D. Devalla et al. EMBO Molecular Medicine
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular and Metabolic Implications of Novel Targeted Cancer Therapies
- (2015) Weijuan Li et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells
- (2015) Gustav Holmgren et al. TOXICOLOGY
- FDA-approved small-molecule kinase inhibitors
- (2015) Peng Wu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells
- (2013) Feng Lan et al. Cell Stem Cell
- Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity
- (2013) Ping Liang et al. CIRCULATION
- Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
- (2013) Bonnie Ky et al. CIRCULATION RESEARCH
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Neuregulin-1 suppresses cardiomyocyte apoptosis by activating PI3K/Akt and inhibiting mitochondrial permeability transition pore
- (2012) Bingzhang Jie et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes
- (2012) S.R. Braam et al. Stem Cell Research
- Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Treated With Sunitinib
- (2011) Christopher J. Richards et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisapride: What can we learn from the rise and fall of a prokinetic?
- (2011) Eamonn MM QUIGLEY Journal of Digestive Diseases
- Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
- (2010) Javid Moslehi et al. CIRCULATION
- Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes
- (2008) Feng Cao et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now